Letter to the Editor
Pyridostigmine bromide versus fludrocortisone in the treatment of orthostatic hypotension in Parkinson's disease – reply
S. R. Schreglmann,
Corresponding Author
S. R. Schreglmann
Department of Neurology, University Hospital Zurich, Zurich
Department of Neurology, Kantonsspital St. Gallen, St. Gallen, Switzerland
Correspondence: S. R. Schreglmann, Sobell Department of Motor Neuroscience and Movement Disorders, University College London (UCL), Institute of Neurology, London, UK (tel.: +44(0)20 344 88604; fax: +44(0)20 344 88642; email:
[email protected]).
Search for more papers by this author F. Büchele,
F. Büchele
Department of Neurology, University Hospital Zurich, Zurich
Search for more papers by this author G. Kägi,
G. Kägi
Department of Neurology, Kantonsspital St. Gallen, St. Gallen, Switzerland
Search for more papers by this author C. R. Baumann,
C. R. Baumann
Department of Neurology, University Hospital Zurich, Zurich
Search for more papers by this author on behalf of
the study authors,
S. R. Schreglmann,
Corresponding Author
S. R. Schreglmann
Department of Neurology, University Hospital Zurich, Zurich
Department of Neurology, Kantonsspital St. Gallen, St. Gallen, Switzerland
Correspondence: S. R. Schreglmann, Sobell Department of Motor Neuroscience and Movement Disorders, University College London (UCL), Institute of Neurology, London, UK (tel.: +44(0)20 344 88604; fax: +44(0)20 344 88642; email:
[email protected]).
Search for more papers by this author F. Büchele,
F. Büchele
Department of Neurology, University Hospital Zurich, Zurich
Search for more papers by this author G. Kägi,
G. Kägi
Department of Neurology, Kantonsspital St. Gallen, St. Gallen, Switzerland
Search for more papers by this author C. R. Baumann,
C. R. Baumann
Department of Neurology, University Hospital Zurich, Zurich
Search for more papers by this author on behalf of
the study authors,
First published: 22 January 2018
No abstract is available for this article.
References
- 1Simões RM, Caldas AC, Ferreira J. Comments on: “Pyridostigmine bromide versus fludrocortisone in the treatment of orthostatic hypotension in Parkinson's disease – a randomized controlled trial”. Eur J Neurol. 2017; 25: e4.
- 2Hoehn MM. Levodopa-induced postural hypotension. Treatment with fludrocortisone. Arch Neurol 1975; 32: 50–51.
- 3Schoffer KL, Henderson RD, O'Maley K, O'Sullivan JD. Nonpharmacological treatment, fludrocortisone, and domperidone for orthostatic hypotension in Parkinson's disease. Mov Disord 2007; 22: 1543–1549.
- 4Wu CK, Hohler AD. Management of orthostatic hypotension in patients with Parkinson's disease. Pract Neurol 2015; 15: 100–104.
- 5Shah PB. Intention-to-treat and per-protocol analysis. CMAJ 2011; 183: 696.
- 6Head SJ, Kaul S, Bogers AJJC, Kappetein AP. Non-inferiority study design: lessons to be learned from cardiovascular trials. Eur Heart J 2012; 33: 1318–1324.
